Al Kraus, Director at Cytosorbents Corp (CTSO), sold 6,774 shares at $6.22 ($42K) on 2015-10-15, disclosed to the SEC on 2015-10-19.
Scheduled sale ($42k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CTSO | SELL | 2020-11-12 | $64K | — | Filing → |
| CTSO | SELL | 2018-08-31 | $376K | — | Filing → |
| CTSO | SELL | 2015-10-13 | $64K | — | Filing → |